Royal Bank of Canada’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56K Sell
1,501
-646
-30% -$21.1K ﹤0.01% 5443
2025
Q4
$63K Sell
2,147
-30,140
-93% -$853K ﹤0.01% 5443
2025
Q3
$847K Buy
32,287
+30,508
+1,715% +$727K ﹤0.01% 4098
2025
Q2
$38K Sell
1,779
-211
-11% -$4.76K ﹤0.01% 6035
2025
Q1
$42K Sell
1,990
-403
-17% -$8.27K ﹤0.01% 5643
2024
Q4
$48K Buy
2,393
+2,216
+1,252% +$45.8K ﹤0.01% 5727
2024
Q3
$3K Buy
+177
New +$2.98K ﹤0.01% 6623

Other funds holding GRDN

Royal Bank of Canada's GRDN Position: Q1 2026 in Review

Royal Bank of Canada reduced its Guardian Pharmacy Services (GRDN) stake by 30% in Q1 2026, selling an estimated $21.1K and leaving 1,501 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #5443.

Royal Bank of Canada first reported a position in GRDN in Q3 2024 and has held it in 7 quarters since. The position peaked at $847K in Q3 2025. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Royal Bank of Canada held 1,501 shares of Guardian Pharmacy Services worth $56K as of Q1 2026.
  • Royal Bank of Canada sold 646 Guardian Pharmacy Services shares in Q1 2026, an estimated $21.1K.
  • Guardian Pharmacy Services made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5443 holding.
  • Royal Bank of Canada first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 7 quarters since.
  • Royal Bank of Canada's Guardian Pharmacy Services position peaked at $847K in Q3 2025.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.